SightfileU.S. market data from official filings

PENUMBRA INC (PEN)

Name: PENUMBRA INC (PEN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001321732 · EDGAR filings · Updated 2026-06-22

PENUMBRA INC (PEN) has reported institutional ownership of 86.0%, with 480 institutional managers holding positions valued at $11.1B per the latest 13F reporting period.

Institutional ownership

86.0%

Institutional managers

480

Reported 13F value

$11.1B

Insider activity

258 trans.

−$71.7M net selling

Latest updates

2026-06-22 — Current report (8-K) filed
2026-05-29 — SD filed
2026-05-21 — Insider transaction reported (Form 4)
2026-05-07 — 425 filed
2026-05-07 — Current report (8-K) filed
2026-05-06 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PENUMBRA INC has 480 institutional holders and institutional ownership of 86.0%.

Insider activity

Insiders reported 258 transactions (0 buys, 199 sells) across 11 reporting insiders, with a net reported value of −$71.7M.

Related companies

JAZZ PHARMACEUTICALS PLC (JAZZ) · ALIGN TECHNOLOGY INC (ALGN) · MEDPACE HLDGS INC (MEDP) · EXELIXIS INC (EXEL) · ENSIGN GROUP INC (ENSG) · BIOMARIN PHARMACEUTICAL INC (BMRN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.